DISEASE SCANNER

Global Incurable Diseases Tracker

Back to Globe
Pulmonary Disease

Chronic Obstructive Pulmonary Disease (COPD)

HIGH SEVERITY

A chronic inflammatory lung disease causing obstructed airflow from the lungs. Includes emphysema (destruction of lung air sacs) and chronic bronchitis (inflammation of bronchial tubes). Progressive disease that makes breathing increasingly difficult over time. Primarily caused by smoking.

Global Affected

384.0M

Countries

97

Symptoms

Shortness of breath (dyspnea)
Chronic cough
Mucus production (sputum)
Wheezing
Chest tightness
Frequent respiratory infections
Fatigue
Unintended weight loss (late stage)
Cyanosis (blue lips/fingernails)

Treatment Options

Smoking cessation
Bronchodilators (short and long-acting)
Inhaled corticosteroids
Combination inhalers
Phosphodiesterase-4 inhibitors
Long-term oxygen therapy
Pulmonary rehabilitation
Vaccinations (flu, pneumococcal, COVID)
Lung volume reduction surgery
Lung transplant
Non-invasive ventilation
Palliative care

Risk Factors

1Cigarette smoking (primary cause)
2Secondhand smoke
3Air pollution
4Occupational dust and chemicals
5Alpha-1 antitrypsin deficiency
6Age >40
7History of childhood respiratory infections
8Asthma
9Low socioeconomic status

Diagnostic Methods

  • 1Spirometry (gold standard)
  • 2Chest X-ray
  • 3CT scan
  • 4Arterial blood gas
  • 5Pulse oximetry
  • 6Alpha-1 antitrypsin testing
  • 76-minute walk test

Prognosis

Progressive disease with no cure. Life expectancy reduced, especially with continued smoking. GOLD classification guides prognosis. Frequent exacerbations worsen prognosis. Respiratory failure common in end-stage. Third leading cause of death worldwide. Early detection and smoking cessation improve outcomes significantly.

Prevention

  • Smoking cessation (most important)
  • Avoid secondhand smoke
  • Minimize occupational exposures
  • Air pollution reduction
  • Vaccinations
  • Alpha-1 antitrypsin screening (if family history)
  • Early treatment of respiratory infections

Research Status

Smoking cessation is most effective intervention. Long-acting bronchodilators (LABA, LAMA) cornerstone of maintenance therapy. Inhaled corticosteroids for frequent exacerbations. Triple therapy (ICS/LABA/LAMA) for advanced disease. Pulmonary rehabilitation improves quality of life. Lung volume reduction surgery and lung transplant for end-stage. Biologics (duplumab) for COPD with type 2 inflammation.

Sources

  • https://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd)
  • https://www.hematology.org/education/patients
  • https://www.ncbi.nlm.nih.gov/books
  • https://rarediseases.org/rare-diseases

Medical Disclaimer

This information is for educational purposes only. Always consult healthcare professionals for medical advice, diagnosis, and treatment.